Shares of Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) were up 1.1% during trading on Wednesday. The stock traded as high as €49.55 and last traded at €49.55. 1,613,123 shares traded hands during trading, The stock had previously closed at €49.03.
Bayer Aktiengesellschaft Stock Up 0.1%
The company has a market capitalization of $49.85 billion, a PE ratio of -56.65, a price-to-earnings-growth ratio of 36.39 and a beta of 0.83. The company has a quick ratio of 0.72, a current ratio of 1.04 and a debt-to-equity ratio of 129.90. The firm has a 50-day moving average of €48.45 and a two-hundred day moving average of €43.05.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
